Return Peptide Library
Tirzepatide
SLevel 1 evidenceTirzepatide
GLP-1 and incretin receptor agonists
Basic Information
Categories
GIP/GLP-1 dual receptor agonist
Overview
Dual GIP/GLP-1 receptor agonist, FDA-approved, with significant weight loss results in clinical trials.
Efficacy Rating
Weight loss, metabolic health, FDA-approved
Evidence Level
S-Rank
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
Semaglutide
Semaglutide
SGLP-1 and incretin receptor agonists
Weight loss, metabolic health, FDA-approved
Dulaglutide
Dulaglutide
AGLP-1 and incretin receptor agonists
Weight loss, metabolic health, FDA-approved
Liraglutide
Liraglutide
AGLP-1 and incretin receptor agonists
Weight loss, metabolic health, FDA-approved
ASC30
ASC30
CGLP-1 and incretin receptor agonists
Research, GLP-1, small molecules
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.